{"updatedAt":"2025-11-27T10:24:29.000Z","createdAt":"2025-11-25T09:43:12.419Z","id":"9G1qa6ERqUfhgSCb","name":"agent4-webscraping-news/article","active":false,"isArchived":false,"nodes":[{"parameters":{},"type":"n8n-nodes-base.manualTrigger","typeVersion":1,"position":[-400,0],"id":"c79aa8bb-1542-469a-8733-344fdb9cbf2f","name":"When clicking ‚ÄòExecute workflow‚Äô"},{"parameters":{"operation":"select","schema":{"__rl":true,"mode":"list","value":"public"},"table":{"__rl":true,"value":"linkai_company_research","mode":"list","cachedResultName":"linkai_company_research"},"returnAll":true,"options":{}},"type":"n8n-nodes-base.postgres","typeVersion":2.6,"position":[-192,0],"id":"52f6220e-3e76-46ac-8ebc-e49a5b1b2b7c","name":"Select rows from a table","credentials":{"postgres":{"id":"mrvj0r5sJJMCTZIg","name":"linkai-supabase-self-hosted"}}},{"parameters":{"options":{}},"type":"n8n-nodes-base.splitInBatches","typeVersion":3,"position":[16,0],"id":"61bbf6ed-e071-4090-932c-facdf40e63a7","name":"Loop Over Items"},{"parameters":{"modelId":{"__rl":true,"value":"gpt-5-mini","mode":"list","cachedResultName":"GPT-5-MINI"},"messages":{"values":[{"content":"=Your job is to generate two things:\n\n1) A detailed, well-structured **Insight Summary** about a company  \n2) A clearly defined **Project Prospecting Scope (PP Scope)** for LinkAI based on the company‚Äôs characteristics, technology maturity, and growth signals.\n\n---\n\n# üì• INPUTS YOU WILL RECEIVE\n\n‚Ä¢ company_name: {{ $json.company_name }}  \n‚Ä¢ sector: {{ $json.sector }}  \n‚Ä¢ overview: {{ $json.overview }}  \n‚Ä¢ business_model: {{ $json.business_model }}  \n‚Ä¢ business_focus: {{ $json.business_focus }}\n\n---\n\n# üß† 1) INSIGHT SUMMARY (MANDATORY)\n\nYou must generate a **single cohesive Insight Summary**, covering:\n\n## 1) Company Understanding  \nExplain:\n‚Ä¢ what the company does  \n‚Ä¢ its domain and industries served  \n‚Ä¢ its positioning in the sector  \n‚Ä¢ its overall business nature  \n\n## 2) Value Proposition Breakdown  \nAnalyse the company‚Äôs:\n‚Ä¢ products/services  \n‚Ä¢ customers & industries  \n‚Ä¢ business model strategy  \n‚Ä¢ key focus areas  \n‚Ä¢ value creation approach  \n‚Ä¢ differentiation and competitive moat  \n\n## 3) Technology, Innovation & R&D Signals  \nIdentify signals around:\n‚Ä¢ AI/ML initiatives  \n‚Ä¢ automation / robotics  \n‚Ä¢ digital transformation maturity  \n‚Ä¢ engineering innovation  \n‚Ä¢ product development  \n‚Ä¢ research labs & patents  \n‚Ä¢ software systems, cloud adoption  \n‚Ä¢ hiring patterns in engineering, data, R&D  \n‚Ä¢ modernisation efforts and tech adoption readiness  \n\n## 4) Growth & Market Signals  \nExplain the company‚Äôs signals around:\n‚Ä¢ expansions  \n‚Ä¢ funding or investments  \n‚Ä¢ partnerships or alliances  \n‚Ä¢ geographical footprint  \n‚Ä¢ acquisitions  \n‚Ä¢ new product lines  \n‚Ä¢ regulatory developments  \n‚Ä¢ any signs of scale, maturity, or emerging opportunities  \n\n---\n\n# üîç WHAT LINKAI EXPECTS YOU TO SEARCH ONLINE (MANDATORY SECTION)\n\nCreate a detailed bullet list explaining **all categories of information LinkAI will later extract online** to discover opportunities.\n\nInclude items like:\n‚Ä¢ latest news articles  \n‚Ä¢ company announcements  \n‚Ä¢ tech news  \n‚Ä¢ AI/ML updates  \n‚Ä¢ automation & digital transformation initiatives  \n‚Ä¢ R&D breakthroughs  \n‚Ä¢ product launches  \n‚Ä¢ patent activity  \n‚Ä¢ partnerships & collaborations  \n‚Ä¢ 2025 roadmaps & strategic plans  \n‚Ä¢ engineering innovation  \n‚Ä¢ investment or expansion news  \n‚Ä¢ hiring & talent signals  \n‚Ä¢ market intelligence reports  \n‚Ä¢ blogs / whitepapers  \n‚Ä¢ leadership interviews  \n\nFor each category, explain **why it matters** specifically for LinkAI‚Äôs 3 verticals:\n1) Marketing & Sales Enablement  \n2) DTM (Digital & Technical Manpower Augmentation)  \n3) Custom AI / Automation Solutions  \n\n---\n\n# üß© 2) PROJECT PROSPECTING SCOPE (PP SCOPE)\n\nBased on all inputs and analysis above, generate a clear **PP Scope** describing:\n\n### A) Opportunity Areas  \nIdentify where LinkAI can help the company across:\n‚Ä¢ AI / automation  \n‚Ä¢ digital transformation  \n‚Ä¢ data engineering  \n‚Ä¢ software engineering  \n‚Ä¢ workflow optimisation  \n‚Ä¢ R&D augmentation  \n‚Ä¢ sales & marketing intelligence  \n‚Ä¢ operational efficiency  \n‚Ä¢ analytics and reporting  \n\n### B) Lead Prospecting Zones  \nDefine zones where LinkAI should look for opportunities such as:\n‚Ä¢ products requiring AI upgrades  \n‚Ä¢ departments undergoing transformation  \n‚Ä¢ regions expanding operations  \n‚Ä¢ hiring-based signals  \n‚Ä¢ R&D or engineering-heavy functions  \n‚Ä¢ leadership discussing innovation  \n‚Ä¢ sustainability, ESG, regulatory-driven initiatives  \n\n### C) What Data LinkAI Should Scrape or Track  \nSpecify:\n‚Ä¢ news  \n‚Ä¢ filings  \n‚Ä¢ job postings  \n‚Ä¢ patents  \n‚Ä¢ investor announcements  \n‚Ä¢ technical blogs  \n‚Ä¢ engineering documentation  \n‚Ä¢ product release notes  \n\n### D) Potential Stakeholders to Target  \nIdentify:\n‚Ä¢ CTO / CIO  \n‚Ä¢ VP Engineering  \n‚Ä¢ Product Directors  \n‚Ä¢ R&D Heads  \n‚Ä¢ Digital Transformation Leads  \n‚Ä¢ Data/AI leadership  \n‚Ä¢ Operations Excellence leaders  \n‚Ä¢ Innovation managers  \n\nGenerate this as a clean, structured written section.\n\n---\n\n# üì§ OUTPUT FORMAT (STRICT)\n\nReturn ONLY:\nA **single combined document** containing:\n1) Insight Summary  \n2) Project Prospecting Scope  \n\nNo JSON.  \nNo bullets outside the structure above.  \nNo queries.  \nNo URLs.\n\nOnly the written summary + PP Scope.\n","role":"system"}]},"options":{}},"type":"@n8n/n8n-nodes-langchain.openAi","typeVersion":1.8,"position":[304,0],"id":"c1617f6b-72fb-48ef-819c-813b86f6558b","name":"Message a model","credentials":{"openAiApi":{"id":"N18vjMppa82mS2di","name":"OpenAi account sir"}}},{"parameters":{"url":"http://69.62.82.163:8000/api/validate","sendQuery":true,"queryParameters":{"parameters":[{"name":"summary","value":"={{ $json.message.content }}"},{"name":"pp_scope","value":"={{ $('Loop Over Items').item.json.business_focus }}"},{"name":"max_results","value":"25"},{"name":"access_token","value":"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"},{"name":"query","value":"null"}]},"sendHeaders":true,"headerParameters":{"parameters":[{"name":"accept","value":"application/json"}]},"options":{}},"type":"n8n-nodes-base.httpRequest","typeVersion":4.2,"position":[768,-32],"id":"797667ef-4186-43f6-9f51-a067de6d2d33","name":"validation-agent","retryOnFail":true,"onError":"continueErrorOutput"},{"parameters":{"errorMessage":"validation agent error  please add credits to open ai account "},"type":"n8n-nodes-base.stopAndError","typeVersion":1,"position":[768,-272],"id":"6e1e629a-e05a-4bdd-9084-0be272a28c5d","name":"Stop and Error"},{"parameters":{"promptType":"define","text":"=input links: {{ $json.validated_urls }}","options":{"systemMessage":"=You are an AI Agent that MUST call the tool ‚Äúinfo_extractor‚Äù for EVERY URL.  \nYou are NOT allowed to analyse ANY URL directly.  \nYou are NOT allowed to answer WITHOUT calling the tool first.  \nYou are NOT allowed to skip tool usage under ANY condition.\n\n-----------------------------------------------------\n# üö® CRITICAL ENFORCEMENT RULE (READ CAREFULLY)\nBefore giving ANY analysis,  \nyou MUST call the tool ‚Äúinfo_extractor‚Äù with the JSON:\n\n{\n  \"url\": \"<the url>\"\n}\n\nIf you do NOT call the tool ‚Üí your response is INVALID.\n\nIf multiple URLs are given, you MUST call the tool ONCE PER URL.\n\nYou must WAIT for each tool response before writing analysis.\n\nYou are STRICTLY NOT ALLOWED to summarise or analyse ANY URL\nUNTIL the tool response is received.\n\n-----------------------------------------------------\n# üéØ TASK AFTER TOOL RESPONSE\n\nFor EACH tool response, extract ONLY from the tool output:\n\n‚Ä¢ summary  \n‚Ä¢ relevance score  \n‚Ä¢ dtm signals  \n‚Ä¢ workload / pain points  \n‚Ä¢ how LinkAI can use it  \n‚Ä¢ priority  \n‚Ä¢ stakeholders  \n\n-----------------------------------------------------\n# üìå REQUIRED OUTPUT FORMAT (STRICT JSON)\n\n{\n  \"url\": \"\",\n  \"relevance_score\": \"\",\n  \"summary\": \"\",\n  \"dtm_signals\": [],\n  \"workload_pain_points\": [],\n  \"how_linkai_can_use\": \"\",\n  \"priority\": \"\",\n  \"target_stakeholders\": []\n}\n\n-----------------------------------------------------\n# üö´ FORBIDDEN\n\n‚Ä¢ You must NOT fabricate data  \n‚Ä¢ You must NOT analyse before tool output  \n‚Ä¢ You must NOT skip tool usage  \n‚Ä¢ You must NOT add external knowledge  \n‚Ä¢ You must NOT output anything except the JSON above  \n‚Ä¢ You must NOT modify the tool call format  \n\n-----------------------------------------------------\n# END OF SYSTEM INSTRUCTIONS\n"}},"type":"@n8n/n8n-nodes-langchain.agent","typeVersion":2.1,"position":[1136,-144],"id":"6e4922f8-7c02-46ae-bfc3-c2e31569213d","name":"AI Agent"},{"parameters":{"model":"openai/gpt-oss-120b","options":{}},"type":"@n8n/n8n-nodes-langchain.lmChatOpenRouter","typeVersion":1,"position":[1136,48],"id":"a9544c9a-b57e-4855-b155-0d7bcccd0be7","name":"OpenRouter Chat Model","credentials":{"openRouterApi":{"id":"aVOKNcsNjOL8t6pA","name":"OpenRouter account-ses"}}},{"parameters":{"toolDescription":"Makes an HTTP request and returns the response data back to agent","url":"={{ /*n8n-auto-generated-fromAI-override*/ $fromAI('URL', ``, 'string') }}","options":{}},"type":"n8n-nodes-base.httpRequestTool","typeVersion":4.2,"position":[1552,-48],"id":"9e497ddf-2657-46d6-9c75-cf1b258eb39a","name":"HTTP Request"},{"parameters":{"sessionIdType":"customKey","sessionKey":"5","contextWindowLength":500},"type":"@n8n/n8n-nodes-langchain.memoryBufferWindow","typeVersion":1.3,"position":[1264,80],"id":"439d5669-f4a1-4e20-b258-e7d53249a3ea","name":"Simple Memory"},{"parameters":{"description":"Use this tool to extract the important information from any webpage HTML. \nIt cleans the HTML, removes UI junk, and returns a concise summary, key points, \nand website details that the agent can use for further analysis.\n","workflowId":{"__rl":true,"value":"bwEg8xw80P5PWXvc","mode":"list","cachedResultName":"information-extractor"},"workflowInputs":{"mappingMode":"defineBelow","value":{},"matchingColumns":[],"schema":[],"attemptToConvertTypes":false,"convertFieldsToString":false}},"type":"@n8n/n8n-nodes-langchain.toolWorkflow","typeVersion":2.2,"position":[1408,64],"id":"d7672c2c-7a50-4791-a7a6-fdf44a58f227","name":"info_extractor"}],"connections":{"When clicking ‚ÄòExecute workflow‚Äô":{"main":[[{"node":"Select rows from a table","type":"main","index":0}]]},"Select rows from a table":{"main":[[{"node":"Loop Over Items","type":"main","index":0}]]},"Loop Over Items":{"main":[[],[{"node":"Message a model","type":"main","index":0}]]},"validation-agent":{"main":[[{"node":"AI Agent","type":"main","index":0}],[{"node":"Stop and Error","type":"main","index":0}]]},"Message a model":{"main":[[{"node":"validation-agent","type":"main","index":0}]]},"OpenRouter Chat Model":{"ai_languageModel":[[{"node":"AI Agent","type":"ai_languageModel","index":0}]]},"HTTP Request":{"ai_tool":[[]]},"Simple Memory":{"ai_memory":[[{"node":"AI Agent","type":"ai_memory","index":0}]]},"info_extractor":{"ai_tool":[[{"node":"AI Agent","type":"ai_tool","index":0}]]}},"settings":{"executionOrder":"v1"},"staticData":null,"meta":{"templateCredsSetupCompleted":true},"pinData":{"Message a model":[{"json":{"index":0,"message":{"role":"assistant","content":"Insight Summary\n\n1) Company Understanding\n- What the company does: Medtronic is a global medical technology and services company that designs, develops, manufactures and commercializes advanced medical devices, integrated therapy systems, and related services to diagnose and treat a broad range of chronic and acute conditions.\n- Domain and industries served: Medtronic operates across cardiac and vascular, diabetes management, spinal and neurosurgery, surgical technologies, respiratory and monitoring, and other specialty medical fields. Customers include hospitals, health systems, clinicians, payers, and, in some therapies (notably diabetes), patients directly.\n- Positioning in the sector: Medtronic is a market leader and one of the largest medical device OEMs worldwide. It is positioned as an innovation-led, clinically-driven provider with a large installed base, broad product portfolio, and significant global distribution and service capabilities.\n- Overall business nature: A mixed B2B and selective B2C commercial model centered on product sales, recurring consumables and service contracts, software-enabled platforms, clinical support services, and integrated systems sold into institutional buyers with long procurement cycles and strong regulatory oversight.\n\n2) Value Proposition Breakdown\n- Products / services: High-complexity implantable and disposable medical devices, therapy delivery systems, surgical tools and robotics-adjacent technology, software for device management and remote monitoring, clinical services, training and support programs, and integrated care solutions.\n- Customers & industries: Hospitals and health systems, specialist clinicians and surgical teams, ambulatory care centers, payers and integrated delivery networks, and patients for home/ambulatory therapies (e.g., chronic disease management).\n- Business model strategy: Combination of capital equipment and recurring revenue (consumables, maintenance, software subscriptions), heavy R&D-driven product lifecycle, strategic partnerships and selective M&A to extend capabilities (software, digital health, services), and global scale to serve diverse regulatory markets.\n- Key focus areas: Clinical efficacy and safety, improving patient outcomes, digital transformation of device-to-cloud workflows, expanding software and services revenue, cost of care reduction, and enabling value-based care models.\n- Value creation approach: Differentiation via clinical evidence, strong regulatory track record, comprehensive ecosystems (device + software + services), long-term clinical partnerships, and scale efficiencies across manufacturing and global distribution.\n- Differentiation and competitive moat: Deep clinical evidence base, regulatory approvals and compliance capability, large installed device base creating network effects for software and services, IP and patents, long-term hospital relationships, and experience in complex supply chains and compliance-heavy manufacturing.\n\n3) Technology, Innovation & R&D Signals\n- AI/ML initiatives: Signals likely include development of predictive analytics for monitoring and remote patient management, algorithmic decision support embedded in devices and platforms, and proofs-of-concept aligning device telemetries to predictive models. Expect internal teams and external partnerships exploring regulatory-compliant AI for clinical decision support.\n- Automation / robotics: Active interest in surgical technologies, robotics-assisted surgery integrations, and device automation to improve procedural precision and workflow efficiency; investments or partnerships to integrate automation into operating-room and catheterization-lab workflows are likely.\n- Digital transformation maturity: High maturity in core business systems and device-cloud integration but heterogeneous maturity across business units; there is continuous modernization toward SaaS delivery, cloud-hosted device management, and telehealth enablement.\n- Engineering innovation: Significant engineering and medical research capability with continuous product development cycles, hardware-software integration challenges, and embedded systems engineering for safety-critical medical devices.\n- Product development: Ongoing pipeline activities across major therapy areas with iterative hardware releases and increasing addition of software features, remote monitoring, and connectivity to value-added services.\n- Research labs & patents: Large, active R&D organization with substantial patent filings and clinical research activity; a culture of clinical trials and long lead-time regulatory programs supports differentiated products.\n- Software systems, cloud adoption: Adoption of cloud infrastructure for device data aggregation, analytics, and clinician dashboards; increasing emphasis on interoperability (APIs, standards) and cybersecurity for device-cloud endpoints.\n- Hiring patterns in engineering, data, R&D: Hiring signals typically show sustained demand for firmware engineers, systems engineers, cloud/data engineers, software developers, clinical data scientists, regulatory software specialists, and AI/ML engineers ‚Äî reflecting modernization and digital expansion.\n- Modernization efforts and tech adoption readiness: Strong readiness for regulated, secure AI/automation solutions when validated clinically; procurement cycles are formal but the company is receptive to solutions that reduce clinical burden, improve outcomes, and have clear regulatory and reimbursement paths.\n\n4) Growth & Market Signals\n- Expansions: Continued global market expansion with strengthening presence in emerging markets, and strategic focus on higher-growth therapy areas and software/services revenue.\n- Funding or investments: Large internal R&D spend and allocations toward digital health, analytics, and services; strategic venture and minority investments in promising digital/AI health startups are likely.\n- Partnerships or alliances: Strategic collaborations with hospitals, health systems, tech firms, cloud providers, and academic centers for co-development, trials, and commercialization of advanced therapies and digital solutions.\n- Geographical footprint: Extensive global footprint across North America, Europe, Asia-Pacific, and emerging markets; operations span manufacturing, distribution, clinical training centers, and service hubs.\n- Acquisitions: Selective acquisitions to shore up digital health, software, and complementary technology capabilities, particularly in AI, remote monitoring, and services.\n- New product lines: Ongoing introduction of device iterations, integrated therapy platforms, and software-as-service offerings to monetize data and provide remote care management.\n- Regulatory developments: Regular regulatory submissions and approvals shape time-to-market; regulatory strategy is a core competency and a gating factor for AI-enabled clinical functionality.\n- Signs of scale, maturity, or emerging opportunities: Large installed base, recurring revenue streams, and investments in software/services indicate maturity combined with opportunities in AI-driven remote monitoring, perioperative workflow automation, predictive maintenance, and data-driven value-based care offerings.\n\nWHAT LINKAI EXPECTS YOU TO SEARCH ONLINE (MANDATORY SECTION)\nFor each category below, LinkAI should extract the items listed and the rationale for why each matters for LinkAI‚Äôs three verticals: 1) Marketing & Sales Enablement, 2) DTM (Digital & Technical Manpower Augmentation), 3) Custom AI / Automation Solutions.\n\n- Latest news articles\n  - What to extract: Press releases, product launch announcements, leadership statements, trial outcomes, regulatory approvals.\n  - Why it matters:\n    - Marketing & Sales: Signals new selling points, positioning changes, go-to-market messaging, and timeframes for campaigns.\n    - DTM: Indicates upcoming engineering workloads, integration needs, and contract staffing windows.\n    - AI/Automation: Reveals areas where AI/automation could be integrated or where clinical validation is needed.\n\n- Company announcements / investor communications\n  - What to extract: Earnings calls, investor presentations, annual reports, strategic roadmaps.\n  - Why it matters:\n    - Marketing & Sales: Prioritization of regions/segments helps shape lead targeting and value propositions.\n    - DTM: Budget signals and hiring plans inform resourcing and proposal sizing.\n    - AI/Automation: Strategic priorities identify programs likely to fund pilot projects or procure custom solutions.\n\n- Tech news and analyst reports\n  - What to extract: Coverage of Medtronic‚Äôs technology strategy, market share analyses, competitive landscape.\n  - Why it matters:\n    - Marketing & Sales: Message differentiation and objection handling for sales teams.\n    - DTM: Benchmarking technical capabilities against peers to propose modern stacks or staffing profiles.\n    - AI/Automation: Identifies gaps where bespoke automation could create competitive advantage.\n\n- AI/ML updates and patents\n  - What to extract: Patent filings, AI algorithms disclosed, regulatory-clearance of algorithmic features.\n  - Why it matters:\n    - Marketing & Sales: Demonstrate thought leadership in AI-enabled therapies to buyers.\n    - DTM: Determine required expertise (ML ops, regulatory AI, clinical validation) and staffing profiles.\n    - AI/Automation: Identify opportunities to augment or replace manual processes with validated models.\n\n- Automation & robotics initiatives\n  - What to extract: Partnerships in surgical robotics, internal robotics projects, procurement of automation tech.\n  - Why it matters:\n    - Marketing & Sales: New revenue plays around robotic-assisted surgery and associated consumables.\n    - DTM: Staffing needs for mechatronics, controls, and systems integration.\n    - AI/Automation: Areas for perception, control, and workflow automation solutions.\n\n- Digital transformation initiatives\n  - What to extract: Cloud migration plans, SaaS product rollouts, interoperability initiatives, cybersecurity programs.\n  - Why it matters:\n    - Marketing & Sales: Offers new product bundles and subscription messaging.\n    - DTM: Demand for cloud engineers, API specialists, security engineers.\n    - AI/Automation: Data platform maturity determines feasibility of model deployments and real-time automation.\n\n- R&D breakthroughs and clinical trial results\n  - What to extract: Trial outcomes, new indications, pivotal study milestones, translational research.\n  - Why it matters:\n    - Marketing & Sales: Clinical evidence shapes claims, case studies, and targeting of early adopters.\n    - DTM: Brings in regulatory engineering and data capture needs for productization.\n    - AI/Automation: High-quality labeled clinical datasets enable model training and validation.\n\n- Product launches and release notes\n  - What to extract: Feature lists, interoperability specs, software versions, firmware updates.\n  - Why it matters:\n    - Marketing & Sales: Timing and feature sets guide campaign materials and competitive positioning.\n    - DTM: Integration work, migration support, and testing demands arise from new releases.\n    - AI/Automation: New telemetry or APIs create integration touchpoints for automation and analytics.\n\n- Patent activity and IP filings\n  - What to extract: New patents, patent portfolios, licensing announcements.\n  - Why it matters:\n    - Marketing & Sales: Demonstrates technological leadership to customers.\n    - DTM: Reveals technical focus areas, indicating hiring and skill needs.\n    - AI/Automation: Identify white-space where LinkAI can propose complementary solutions without IP conflict.\n\n- Partnerships & collaborations\n  - What to extract: Strategic alliances with cloud providers, tech firms, universities, hospitals, startups.\n  - Why it matters:\n    - Marketing & Sales: Co-marketing or channel partnerships to accelerate reach.\n    - DTM: Joint development projects requiring augmented teams or specialized skills.\n    - AI/Automation: Opportunities for joint pilots and access to clinical partners or datasets.\n\n- 2025 roadmaps & strategic plans (and future guidance)\n  - What to extract: Multi-year strategy slides, transformation initiatives, priority investments.\n  - Why it matters:\n    - Marketing & Sales: Align GTM to strategic priorities to get engagement from procurement and innovation buyers.\n    - DTM: Plan resource offers that map to multi-year hiring curves.\n    - AI/Automation: Identify where pilots and scalable deployments are likely to be funded.\n\n- Hiring & talent signals\n  - What to extract: Job postings, recruiting drives, new labs or engineering centers, LinkedIn hiring spikes.\n  - Why it matters:\n    - Marketing & Sales: Which teams are scaling and therefore receptive to vendor outreach.\n    - DTM: Direct indicator of required skillsets and immediate staffing gaps LinkAI can fill.\n    - AI/Automation: Hiring for data science, ML, MLOps, firmware, and cloud indicates readiness to adopt custom solutions.\n\n- Market intelligence and competitive moves\n  - What to extract: Competitor product launches, pricing moves, hospital procurement trends.\n  - Why it matters:\n    - Marketing & Sales: Competitive positioning used to sharpen messaging and win-loss strategies.\n    - DTM: Competing tech stacks reveal staffing and tooling that may be needed.\n    - AI/Automation: Identify where competitors leverage automation to gain clinical or operational advantages.\n\n- Regulatory filings & approvals\n  - What to extract: FDA/CE approvals, submissions, recalls, safety notices.\n  - Why it matters:\n    - Marketing & Sales: Messaging that complies with claims around cleared features.\n    - DTM: Regulatory engineering resource needs for compliance, documentation, and validation.\n    - AI/Automation: Defines constraints and validation requirements for AI-enabled clinical features.\n\n- Technical blogs, whitepapers, and engineering documentation\n  - What to extract: Architecture diagrams, API docs, developer portals, interoperability specs.\n  - Why it matters:\n    - Marketing & Sales: Technical differentiators to include in mid-market and enterprise conversations.\n    - DTM: Basis for scoping integration, migration, and staffing plans.\n    - AI/Automation: Essential for solution design, integration points, and secure deployment.\n\n- Investor / M&A activity\n  - What to extract: Divestitures, acquisitions, venture investments, VC portfolio activity.\n  - Why it matters:\n    - Marketing & Sales: New capabilities/intended markets that open cross-sell opportunities.\n    - DTM: Integration projects from M&A that need temporary surge capacity.\n    - AI/Automation: Acquired product/data assets that enable rapid pilots or joint solutions.\n\n- Customer case studies and advisory board outputs\n  - What to extract: Clinical partners‚Äô testimonials, advisory committee statements, health system pilots.\n  - Why it matters:\n    - Marketing & Sales: Credibility and use cases for campaigns.\n    - DTM: Understand operating environments and integration complexity.\n    - AI/Automation: Access to clinical partners as pilot sites and validation cohorts.\n\nProject Prospecting Scope (PP Scope)\n\nA) Opportunity Areas ‚Äî Where LinkAI can help\n- AI / Automation\n  - Build and validate clinical-grade ML models for predictive monitoring (device telemetry, post-op complications, readmission risk).\n  - Develop MLOps pipelines for regulated model lifecycle management (validation, auditing, explainability).\n  - Automate perioperative and clinical workflows (scheduling, device provisioning, OR instrument tracking).\n- Digital Transformation\n  - Modernize legacy device-management systems to cloud-native, secure, multi-tenant SaaS platforms.\n  - Implement interoperability layers (APIs, HL7/FHIR adapters) for device-cloud-to-EHR integration.\n- Data Engineering & Analytics\n  - Data ingestion, normalization and governance for large-scale telemetry and device logs.\n  - Build data warehouses/lakes and real-time streaming analytics for operational and clinical insights.\n- Software & Systems Engineering\n  - Augment firmware, embedded systems, and backend engineering teams for release cadence acceleration.\n  - Provide cybersecurity engineering for device connectivity, secure OTA updates, and compliance.\n- Workflow Optimization & Operational Efficiency\n  - Process mining and automation to reduce device downtime, optimize supply/consumable logistics, and improve service scheduling.\n  - Predictive maintenance solutions for manufacturing and deployed devices.\n- R&D Augmentation\n  - Provide data scientists, computational biologists, and simulation engineers to accelerate clinical signal discovery and device prototyping.\n  - Support clinical trial data pipelines and analytics to shorten time-to-evidence.\n- Sales & Marketing Intelligence\n  - Lead enrichment, target account prioritization, and messaging personalization informed by product-launch and regional expansion signals.\n  - Technical content creation and sales enablement assets grounded in engineering/clinical features.\n- Analytics and Reporting\n  - Build executive dashboards and automated reporting for performance, quality, and regulatory reporting.\n\nB) Lead Prospecting Zones ‚Äî Where LinkAI should look for wins\n- Product lines requiring AI upgrades\n  - Remote monitoring and diagnostics platforms, diabetes management platforms, perioperative systems, surgical technologies and robotics adjunct software.\n- Business units / departments undergoing transformation\n  - Digital health units, cloud platform teams, connected-care product groups, clinical data science teams, R&D engineering centers.\n- Regions expanding operations\n  - Emerging-market commercialization teams and service hubs where deployments require local integration and scalable support.\n- Hiring-based signals\n  - Teams with spike hiring in ML, cloud, embedded systems, cybersecurity, and data engineering.\n- R&D / engineering-heavy functions\n  - Clinical evidence generation teams, product platform engineering, embedded firmware, and regulatory software compliance groups.\n- Leadership signals (innovation-focused)\n  - Execs publicly discussing AI, digital transformation, or strategic priorities for software/services expansion.\n- Regulatory and reimbursement-driven initiatives\n  - Programs aimed at enabling value-based care, remote monitoring reimbursement, or AI/algorithmic device clearances.\n\nC) What Data LinkAI Should Scrape or Track\n- News and press releases (product launches, regulatory approvals, strategic announcements)\n- Earnings transcripts, investor presentations, and annual/quarterly reports\n- Job postings and hiring trends (engineering, data science, clinical informatics)\n- Patent filings and IP portfolio changes\n- Clinical trial registries and published trial outcomes\n- Partnership and alliance announcements (cloud providers, academic collaborations)\n- Product release notes, SDKs, developer portal updates, and API documentation\n- Regulatory filings and safety notices (FDA, CE and equivalents)\n- M&A and venture investment activity\n- Technical blogs, whitepapers, and conference presentations by Medtronic engineers and clinicians\n- Procurement and RFP notices from large health systems (where available)\n- Social signals from leadership and engineering teams (conference talks, webinars, LinkedIn posts)\n- Supply chain and manufacturing notices (capacity expansions, supplier changes)\n\nD) Potential Stakeholders to Target\n- Chief Technology Officer (CTO) / Chief Information Officer (CIO): strategic cloud, platform, and digital roadmap stakeholders.\n- VP / SVP Engineering: platform, product engineering, and firmware teams who need executional augmentation.\n- Head of R&D / Chief Medical Officer / VP Clinical Affairs: clinical validation, trials, and evidence generation.\n- Head of Digital Health / VP Connected Care: owners of device-cloud platforms and remote monitoring services.\n- Director / VP of Data Science / AI: model development and MLOps leaders for clinical AI adoption.\n- Product Directors and Program Managers for key therapy areas (diabetes, surgical robotics, cardiac)\n- Head of Regulatory Engineering / Quality Assurance: compliance and validation owners for regulated software and AI.\n- Head of Clinical Informatics / Interoperability: EHR integration and standards adoption decision-makers.\n- Operations Excellence / VP Service Operations: target for predictive maintenance and field service automation.\n- Procurement / Vendor Management leaders: buyers for professional services, SaaS, and integration projects.\n- Innovation / Strategic Partnerships Manager: scouts for pilots and co-development opportunities with startups or vendors.\n\nExecution notes for LinkAI engagement\n- Prioritize pilot projects that can produce measurable clinical or operational ROI within defined regulatory constraints (e.g., retrospective validation, non-diagnostic augmentation workflows).\n- Propose DTM engagements that combine embedded firmware, cloud engineering, and regulated software QA expertise to reduce onboarding friction.\n- Offer a composable stack: modular MLOps + interoperability adapters + security-by-design components to match Medtronic‚Äôs regulated environment.\n- Bundle Marketing & Sales Enablement services with technical pilots: case studies from development engagements are high-value for commercial teams to accelerate broader adoption.\n\nEnd of document.","refusal":null,"annotations":[]},"finish_reason":"stop"}}],"validation-agent":[{"json":{"validated_urls":["https://www.medtroniclabs.org/","https://www.delveinsight.com/report-store/thrombectomy-devices-market?trk=article-ssr-frontend-pulse_little-text-block","https://www.bloomberg.com/profile/company/SLNT:US","https://news.medtronic.com/five-healthcare-technology-trends-in-2024-newsroom","https://www.globenewswire.com/news-release/2024/07/01/2906539/0/en/Medtronic-Digital-Transformation-Strategy-Report-2024-Accelerators-Incubators-and-Other-Innovation-Programs.html","https://biotechhealthx.com/biotech-news/medtronic-mdt-reports-9-billion-revenue-surge/","https://blog.arnaudknobloch.com/medtronic/","https://www.linkedin.com/pulse/europe-electric-dermatome-market-size-trends-ooiwc"],"validation_score":8}}]},"versionId":"cd04055d-438f-4f35-bf47-bcdf6b6d1857","triggerCount":0,"shared":[{"updatedAt":"2025-12-11T08:33:33.914Z","createdAt":"2025-12-11T08:33:33.914Z","role":"workflow:owner","workflowId":"9G1qa6ERqUfhgSCb","projectId":"Gh4K029Sunajg0dH"}],"tags":[]}